BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32749654)

  • 21. Peripheral blood mononuclear cells - Can they provide a clue to the pathogenesis of Graves' Orbitopathy?
    Basak M; Sanyal T; Kar A; Bhattacharjee P; Das M; Chowdhury S
    Endocrine; 2022 Feb; 75(2):447-455. PubMed ID: 34545512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current insights into the pathogenesis of Graves' orbitopathy.
    Eckstein AK; Johnson KT; Thanos M; Esser J; Ludgate M
    Horm Metab Res; 2009 Jun; 41(6):456-64. PubMed ID: 19530272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy.
    Nicolì F; Lanzolla G; Mantuano M; Ionni I; Mazzi B; Leo M; Sframeli A; Posarelli C; Maglionico MN; Figus M; Nardi M; Marcocci C; Marinò M
    J Endocrinol Invest; 2021 Mar; 44(3):581-585. PubMed ID: 32648002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors?
    Wiersinga WM
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2386-94. PubMed ID: 21677036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor.
    Plöhn S; Hose M; Schlüter A; Michel L; Diaz-Cano S; Hendgen-Cotta UB; Banga JP; Bechrakis NE; Hansen W; Eckstein A; Berchner-Pfannschmidt U
    Thyroid; 2019 Sep; 29(9):1286-1301. PubMed ID: 31237525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bioluminescence assay for thyrotropin receptor antibodies predicts serum thyroid hormone levels in patients with de novo Graves' disease.
    Hovens GC; Buiting AM; Karperien M; Ballieux BE; van der Pluijm G; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):429-35. PubMed ID: 16584516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse model of Graves' orbitopathy induced by the immunization with TSHR A and IGF-1R α subunit gene.
    Wu R; Li N; Wang X; Wang S; Tan J; Wang R; Zheng W
    J Endocrinol Invest; 2024 Apr; ():. PubMed ID: 38662129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
    Dik WA; Virakul S; van Steensel L
    Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts.
    Kumar S; Schiefer R; Coenen MJ; Bahn RS
    Thyroid; 2010 Jan; 20(1):59-65. PubMed ID: 20017620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Early Wave of Macrophage Infiltration Intertwined with Antigen-Specific Proinflammatory T Cells and Browning of Adipose Tissue Characterizes the Onset of Orbital Inflammation in a Mouse Model of Graves' Orbitopathy.
    Philipp S; Horstmann M; Hose M; Daser A; Görtz GE; Jesenek C; Flögel U; Hansen W; Bechrakis N; Banga JPS; Eckstein A; Berchner-Pfannschmidt U
    Thyroid; 2022 Mar; 32(3):283-293. PubMed ID: 34779257
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyrotropin Receptor Antagonism by a Novel Small Molecule: Preclinical
    Kahaly GJ; Steiner L; van der Lee MMC; van Achterberg TAE; Arends RJ; Karstens WFJ; Weirauch T; Henseling J; Frommer L; Wolf J; George A
    Thyroid; 2023 Jun; 33(6):732-742. PubMed ID: 37016815
    [No Abstract]   [Full Text] [Related]  

  • 33. Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review.
    Seo S; Sánchez Robledo M
    J Endocrinol Invest; 2018 Dec; 41(12):1457-1468. PubMed ID: 30194634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of thyroid stimulating (TSAB)- and thyrotropin stimulation blocking (TSBAB) antibodies with CHO cell lines expressing different TSH-receptor numbers.
    Wallaschofski H; Paschke R
    Clin Endocrinol (Oxf); 1999 Mar; 50(3):365-72. PubMed ID: 10435063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Long-Term Graves' Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies.
    Diana T; Holthoff HP; Fassbender J; Wüster C; Kanitz M; Kahaly GJ; Ungerer M
    Eur Thyroid J; 2020 Dec; 9(Suppl 1):51-58. PubMed ID: 33511085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forkhead Transcription Factor FOXO1 Is Regulated by Both a Stimulatory Thyrotropin Receptor Antibody and Insulin-Like Growth Factor-1 in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.
    Kumar S; Coenen M; Iyer S; Bahn RS
    Thyroid; 2015 Oct; 25(10):1145-50. PubMed ID: 26213859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
    Zhang M; Ding X; Wu LP; He MQ; Chen ZY; Shi BY; Wang Y
    Thyroid; 2021 Apr; 31(4):638-648. PubMed ID: 33076782
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.
    van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
    Thyroid; 2011 Feb; 21(2):169-76. PubMed ID: 20954819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study.
    Diana T; Brown RS; Bossowski A; Segni M; Niedziela M; König J; Bossowska A; Ziora K; Hale A; Smith J; Pitz S; Kanitz M; Kahaly GJ
    J Clin Endocrinol Metab; 2014 May; 99(5):1648-55. PubMed ID: 24517152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid Stimulating Hormone Receptor Antibodies in Thyroid Eye Disease-Methodology and Clinical Applications.
    Diana T; Kahaly GJ
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S13-S19. PubMed ID: 29771755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.